| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2376373
Max Phase: Preclinical
Molecular Formula: C32H35N5O3
Molecular Weight: 537.66
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCN(CC)C(=O)C1CCN(C(=O)Nc2cccc(Cn3nc(-c4cccc5ccccc45)ccc3=O)c2)CC1
Standard InChI: InChI=1S/C32H35N5O3/c1-3-35(4-2)31(39)25-17-19-36(20-18-25)32(40)33-26-12-7-9-23(21-26)22-37-30(38)16-15-29(34-37)28-14-8-11-24-10-5-6-13-27(24)28/h5-16,21,25H,3-4,17-20,22H2,1-2H3,(H,33,40)
Standard InChI Key: SAMJJGQZDCHXGY-UHFFFAOYSA-N
Associated Targets(non-human)
Butyrylcholinesterase 745 Activities
Acetylcholinesterase 2577 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 537.66 | Molecular Weight (Monoisotopic): 537.2740 | AlogP: 5.22 | #Rotatable Bonds: 7 |
| Polar Surface Area: 87.54 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 13.34 | CX Basic pKa: | CX LogP: 4.08 | CX LogD: 4.08 |
| Aromatic Rings: 4 | Heavy Atoms: 40 | QED Weighted: 0.35 | Np Likeness Score: -1.85 |
References
| 1. Xing W, Fu Y, Shi Z, Lu D, Zhang H, Hu Y.. (2013) Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors., 63 [PMID:23466605] [10.1016/j.ejmech.2013.01.056] |
Source
Source(1):